Related references
Note: Only part of the references are listed.Utility of combining PIVKA-II and AFP in the sur- veillance and monitoring of hepatocellular carci- noma in the Asia-Pacific region
Do Young Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
The impact of biological features for a better prediction of posttransplant hepatocellular cancer recurrence
Quirino Lai et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2022)
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal et al.
HEPATOLOGY (2022)
DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study
Prashant Kotwani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study
Ming-Da Wang et al.
INTERNATIONAL JOURNAL OF SURGERY (2022)
Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation
Shin Hwang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
Karim J. Halazun et al.
JAMA SURGERY (2021)
Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score
Jan Lerut et al.
UPDATES IN SURGERY (2021)
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis
Ming Yang et al.
PLOS ONE (2019)
Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce a-Fetoprotein
Vatche G. Agopian et al.
JAMA SURGERY (2017)
Des-gamma-carboxy prothrombin in hepatocellular cancer patients waiting for liver transplant: a systematic review and meta-analysis
Quirino Lai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score
Quirino Lai et al.
ANNALS OF SURGERY (2016)
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria
Jeong-Hoon Lee et al.
ANNALS OF SURGERY (2016)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Nicolas Pote et al.
JOURNAL OF HEPATOLOGY (2015)
Combinations of Biomarkers and Milan Criteria for Predicting Hepatocellular Carcinoma Recurrence After Liver Transplantation
Roongruedee Chaiteerakij et al.
LIVER TRANSPLANTATION (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma
Junichi Shindoh et al.
TRANSPLANT INTERNATIONAL (2014)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
Young Eun Chon et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation
K. Shirabe et al.
BRITISH JOURNAL OF SURGERY (2011)
Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis of 15 Years of Experience
Vincenzo Mazzaferro et al.
LIVER TRANSPLANTATION (2011)
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
E. Vibert et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Liver transplantation for hepatocellular carcinoma: the Kyoto experience
Yasutsugu Takada et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2010)
Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma
M. Fujiki et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Akinobu Taketomi et al.
TRANSPLANTATION (2009)
Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation
Takashi Ito et al.
LIVER TRANSPLANTATION (2007)
Extending indication: Role of living donor liver transplantation for hepatocellular carcinoma
Sol Todo et al.
LIVER TRANSPLANTATION (2007)
Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration
Jan P. Vandenbroucke et al.
PLOS MEDICINE (2007)
Proportional hazards models with frailties and random effects
J O'Quigley et al.
STATISTICS IN MEDICINE (2002)
Share Paper
